Bio Medica Laboratories (NSE:BMLL) Research & Development: ₹ Mil (TTM As of Mar. 2025)


NSE:BMLL Bio Medica Laboratories Ltd NSE:BMLL
14 GF Score
Price ₹144.10
! 2 Warning Signs
View Full Analysis

What is Bio Medica Laboratories Research & Development?

Bio Medica Laboratories NSE:BMLL +0.49% 14 Research & Development is ₹ Mil as of Mar. 2025. GuruFocus rates NSE:BMLL with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Bio Medica Laboratories's Research & Development for the six months ended in Mar. 2025 was ₹0.0 Mil. Bio Medica Laboratories does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Mar. 2025.

Bio Medica Laboratories  (NSE:BMLL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bio Medica Laboratories Research & Development Related Terms

Bio Medica Laboratories Research & Development Historical Data

* Premium members only.

The historical data trend for Bio Medica Laboratories's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Medica Laboratories Research & Development Chart

Bio Medica Laboratories Annual Data
Trend Mar23 Mar24 Mar25
Research & Development
0.00 0.00 0.00

Bio Medica Laboratories Semi-Annual Data
Mar23 Mar24 Mar25
Research & Development 0.00 0.00 0.00
NSE:BMLL
14GF Score
Bio Medica Laboratories Ltd NSE:BMLL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Medica Laboratories Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹ Mil mean?
Bio Medica Laboratories (NSE:BMLL) has a Research & Development of ₹ Mil as of Mar. 2025. Research and development expense is the total cost for research and development activities. View historical data on Bio Medica Laboratories and its competitors.
Is Bio Medica Laboratories' Research & Development too high?
Bio Medica Laboratories' current Research & Development is ₹ Mil. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' Research & Development compare to ISRG and BDX?
Bio Medica Laboratories' Research & Development of ₹ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Bio Medica Laboratories and its competitors. Bio Medica Laboratories's current Research & Development is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current Research & Development of ₹ Mil. The current Research & Development is ₹ Mil. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current Research & Development is ₹ Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio Medica Laboratories Business Description

Address Sanwer Road, Plot No. 11B-11C, Sector-E, Industrial Area, Industrial Estate - Indore, Indore, MP, IND, 452015
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score

Get the complete analysis for NSE:BMLL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹144.10
Price